ALS Masitinib Asthma Benralizumab Dupilumab Tiotropium bromide Tralokinumab Bacterial infections Amoxicilline / omeprazol / rifabutin Cadazolid Eravacycline Liposomaal amikacine Meropenem / vaborbactam Omadacycline Ozenoxacine Recombinant vaccin voor meningokokken groep B Bladder cancer Atezolizumab Durvalumab / Tremelimumab Pembrolizumab Ramucirumab Blood clotting Andexanet alfa Betrixaban Ciraparantag Vonicog alfa Bowel diseases Alicaforsen Pouchitis Ulcerative colitis (UC) Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue Lubiprostone Masitinib Remestemcel-L Rifaximin Tofacitinib Brain cancer Brain cancer vaccine Depatuxizumab mafodotin Breast cancer Abemaciclib Atezolizumab Fulvestrant Neratinib Olaparib Pembrolizumab Ribociclib Breast cancer, advanced metastatic, HR+ and HER2-, in combination with fulvestrant, postmenopausal women and men, 1L en 2L Breast cancer, advanced metastatic, HR+ and HER2-, in combination with tamoxifen and goserelin or a non-steroidal aromatase inhibitor (NSAI) and goserelin, premenopausal women. Trastuzumab Veliparib Breast cancer; early-stage triple-negative - neoadjuvant therapy with carboplatin Breast cancer; HER2-negative metastatic or locally advanced unresectable BRCA-associated - first to third-line in combination with carboplatin and paclitaxel. COPD Fluticasone furoate / umeclidinium (bromide) / vilanterol (trifenatate) Glycopyrrolate / formoterol Mepolizumab Cardiovascular diseases Avacopan Canakinumab Evolocumab Prasugrel Rivaroxaban Tocilizumab Colon cancer Nivolumab Cystic fibrosis Tezacaftor / ivacaftor Dementia Leuco-methylthioninium Alzheimer’s disease, mild-to-moderate. Dementia, behavioural variant frontotemporal. Diabetes Dapagliflozine Ertugliflozin Ertugliflozin (L-pyroglutamic acid) / metformin (hydrochloride) Ertugliflozin (L-pyroglutamic acid) / sitagliptin (phosphate monohydrate) Exenatide Glibenclamide Semaglutide Epilepsy Vigabatrin Eye disorders Adalimumab Cenegermin Ciclosporin Keratoconjunctivitis sicca (or dry eye disease), moderate-to-severe and specifically in patients with atopic keratoconjunctivitis. Treatment of severe vernal keratoconjunctivitis in children from 4 years of age and adolescents. Mercaptamine Pegpleranib Voretigene neparvovec Graft versus Host Ibrutinib Haemophilia Damoctocog alfa pegol Emicizumab Rurioctocog alfa pegol Viable T-cells Head and neck cancer Afatinib Durvalumab / Tremelimumab Pembrolizumab Headache Eptinezumab Erenumab Galcanezumab Heart failure Allogenic immunomodulatory progenitor cells Autologous stem cells Ularitide Valsartan / sacubitril Hemostasis Human fibrinogen / Human thrombin Hormonal disorders Abaloparatide Cinacalcet Enclomifene (citrate) Pasireotide LAR Prasterone Recombinant parathyroid hormone Kidney cancer Atezolizumab Ipilimumab Sunitinib Leukemia Blinatumomab Adults with minimal residual disease (MRD) positive B-cell precursor acute lymphoblastic leukaemia (ALL). Relapsed / Refractory Ph+ Adult Acute Lymphoblastic Leukemia (ALL). Relapsed / Refractory precursor-B Acute Lymphoblastic Leukemia (ALL) in children. Bosutinib Cytarabine / daunorubicin (liposomaal) Dasatinib Gemtuzumab ozogamicin Idelalisib Inotuzumab ozogamicin Midostaurin Nilotinib Tisagenlecleucel Venetoclax in combinatie met rituximab Liver cancer Nivolumab Regorafenib Liver diseases Obeticholic acid Lung cancer Alectinib Anamorelin Atezolizumab NSCLC non-squamous 1st line. Tecentriq is als monotherapie geïndiceerd voor de behandeling van volwassen patiënten met lokaal gevorderde of gemetastaseerde niet-kleincellige longkanker (NSCLC) na eerdere behandeling met chemotherapie. Patiënten met EGFR-activerende mutaties of ALK-positieve mutaties moeten ook doelgerichte behandeling hebben ontvangen voor ze Tecentriq krijgen. Avelumab Brigatinib Durvalumab Durvalumab / Tremelimumab Osimertinib Pembrolizumab Rociletinib Rovalpituzumab tesirine Veliparib Lymphoma Axicabtagene ciloleucel Brentuximab vedotin Ibrutinib Follicular lymphoma (FL), relapsed / refractory. Mantle cell lymphoma (MCL), 1L. Marginal zone lymphoma (MZL), relapsed / refractory. Non-germinal center B-cell-like (non-GCB) diffuse large B-cell lymphoma (DLBCL), 1L. Obinutuzumab Tisagenlecleucel Mesothelioma Nintedanib Nivolumab Metabolic diseases Asfotase alfa Burosumab Cerliponase alfa Chenodeoxycholzuur Cholic acid Cyclodextrine (Hydroxypropyl betadex) Ibiglustat Idursulfase-IT Levamisole (hydrochloride) Metreleptin Migalastat Neod001 Patiromer Pegvaliase Sebelipase alfa Sodium benzoate Sodium zirconium cyclosilicate Velmanase alfa Vestronidase alfa Volanesorsen (sodium) Multiple Myeloma Denosumab Pembrolizumab Plitidepsin Multiple sclerosis Biotin Cladribine Masitinib Ocrelizumab Ozanimod Siponimod Muscular diseases Botulinum A toxin Lower limb spasticity (LLS), in adults post stroke or traumatic brain injury (TBI). Lower limb spasticity (LLS), post stroke. Eculizumab Eteplirsen Idebenone Mexiletine HCl Nusinersen Valbenazine Neuroendocrine cancer Lutetium-177 Telotristat etiprate Other chronic immune diseases Budesonide Forigerimod (Rigerimod) Icatibant Lesinurad / allopurinol Other hematology Romiplostim Ropeginterferon alfa-2b Other infectious diseases Benznidazole Other lung Alpha-1-antitrypsin Mepolizumab Other neurological disorders Botulinum A toxin CM-AT / CM-4612 Esketamine Patisiran Other viral infections Bictegravir / emtricitabine / tenofovir alafenamide fumaraat Darunavir / cobicistat / emtricitabine / tenofovir alafenamide Dolutegravir /rilpivirine Emtricitabine / tenofovir disproxil fumarate Glecaprevir / pibrentasvir Letermovir Peramivir Recombinant zoster vaccin Sofosbuvir / velpatasvir / voxilaprevir Ovarian cancer Niraparib (tosylate monohydrate) Olaparib Paclitaxel Rucaparib Veliparib Pancreatic cancer Olaparib Parkinson's Pimavanserin Prostate cancer Abiraterone Olaparib Padeliporfin Psychiatry Brexpiprazole Cariprazine (hydrochloride) Esketamine Lurasidone Rheumatism Adalimumab Sirukumab Upadacitinib Skin cancer Avelumab Binimetinib Encorafenib Nivolumab Pembrolizumab Skin diseases Abatacept Adalimumab Baricitinib Certolizumab pegol Dupilumab Guselkumab Ixekizumab Nemolizumab Risankizumab Tildrakizumab Tofacitinib Sleep disorders Melatonin Pitolisant Tasimelteon Stomach cancer Atezolizumab Masitinib Pembrolizumab Thrombosis Caplacizumab Unknown Anacetrapib MABp1